And caused by high staff costs with no hint why this has increased by 50% this quarter, and last quarter it has already increased by 50%, this can't all be on sales rep??? That is too much for them. These better bring in significant revenue and/or just once-off start-up cost for revenue increase.
I see the worst case is to start again, sell all their commercial products/assets, do a massive staff cut and start again as bio-stock startup with all their focused turned to IMMU to speed the development, using those capitals obtain from the sale as start-up cost, their current MC is already the value of a start-up bio-tech company right now.
- Forums
- ASX - By Stock
- AVR
- Ann: Preliminary Final Report for period to 31 December 2018
Ann: Preliminary Final Report for period to 31 December 2018, page-14
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.09 |
Change
-0.210(1.37%) |
Mkt cap ! $318.9M |
Open | High | Low | Value | Volume |
$15.10 | $15.38 | $15.02 | $55.26K | 3.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 98 | $15.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.57 | 779 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 98 | 15.090 |
1 | 26 | 15.020 |
1 | 15 | 15.010 |
2 | 582 | 15.000 |
1 | 1000 | 14.850 |
Price($) | Vol. | No. |
---|---|---|
15.570 | 779 | 1 |
15.940 | 554 | 1 |
15.950 | 848 | 2 |
16.030 | 999 | 1 |
16.500 | 1171 | 2 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online